The effector functions of NKG2C have largely been demonstrated in the context of viral infections, however, they may also operate in cancer as NKG2C+ NK cells have recently demonstrated potent cytotoxicity against HLA-C:KIR mismatched leukemic cells [16]. Here, KLRC2 is linked to cancer.